1. Home
  2. VERA vs WINA Comparison

VERA vs WINA Comparison

Compare VERA & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • WINA
  • Stock Information
  • Founded
  • VERA 2016
  • WINA 1988
  • Country
  • VERA United States
  • WINA United States
  • Employees
  • VERA N/A
  • WINA N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • WINA Other Specialty Stores
  • Sector
  • VERA Health Care
  • WINA Consumer Discretionary
  • Exchange
  • VERA Nasdaq
  • WINA Nasdaq
  • Market Cap
  • VERA 1.6B
  • WINA 1.5B
  • IPO Year
  • VERA 2021
  • WINA 1993
  • Fundamental
  • Price
  • VERA $31.74
  • WINA $429.04
  • Analyst Decision
  • VERA Buy
  • WINA Strong Buy
  • Analyst Count
  • VERA 8
  • WINA 1
  • Target Price
  • VERA $64.63
  • WINA $445.00
  • AVG Volume (30 Days)
  • VERA 1.8M
  • WINA 74.2K
  • Earning Date
  • VERA 05-06-2025
  • WINA 07-16-2025
  • Dividend Yield
  • VERA N/A
  • WINA 2.60%
  • EPS Growth
  • VERA N/A
  • WINA 2.14
  • EPS
  • VERA N/A
  • WINA 11.19
  • Revenue
  • VERA N/A
  • WINA $83,099,300.00
  • Revenue This Year
  • VERA N/A
  • WINA $6.56
  • Revenue Next Year
  • VERA N/A
  • WINA $3.57
  • P/E Ratio
  • VERA N/A
  • WINA $38.37
  • Revenue Growth
  • VERA N/A
  • WINA 0.33
  • 52 Week Low
  • VERA $18.53
  • WINA $295.79
  • 52 Week High
  • VERA $51.61
  • WINA $434.87
  • Technical
  • Relative Strength Index (RSI)
  • VERA 74.66
  • WINA 72.97
  • Support Level
  • VERA $18.76
  • WINA $414.20
  • Resistance Level
  • VERA $20.21
  • WINA $430.20
  • Average True Range (ATR)
  • VERA 1.13
  • WINA 10.12
  • MACD
  • VERA 0.68
  • WINA -1.03
  • Stochastic Oscillator
  • VERA 92.25
  • WINA 80.82

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: